logo
logo
logo

logo

HOME/ PUBLICATIONS/PATENTS/2015

Publications / Patents >
2022 >
2021 >
2020 >
2019 >
2018 >
2017 >
2016 >
2015 >
2014 >
2013 >
2012 >
2011 >
2010/2009 >
Patents >
Book Chapters >

Publications in 2015

Publications are the primary method for reporting and long-term documentation of the research conducted at the NIPER-Hyderabad. Here the list of publications published in year wise...


  1. Kamal, A.; Sathish, M.; Prasanthi, A. V. G.; Chetna, J.; Tangella, Y.; Srinivasulu, V.; Shankaraiah, N.; Alarifi, A.; An efficient one-pot oxidative decarboxylation tandem aromatization of tetrahydro-β-carbolines by using N-chlorosuccinimide: Total synthesis of norharmane, harmane and eudistomins; RSC Adv. 2015, 5, 90121–90126.
  2. Sharma, P.; Senwar, K. R.; Jeengar, M. K.; Reddy, T. S.; Naidu, V. G. M.; Kamal, A.; Shankaraiah, N.; H2O-Mediated isatin spiro-epoxide ring opening with NaCN: Synthesis of novel 3-tetrazolylmethyl-3-hydroxy-oxindole hybrids and their anticancer evaluation; Eur. J. Med. Chem. 2015, 104, 11–24.
  3. Wajid Syed, Tasneem Mohammed, Arifuddin Mohommed, Mohamed N Al-Arifi .; Transition metal complexes mediated efficient and facile cleavage of oximes and phenylhydrazone to carbonyl compounds; Asian Journal of Pharmaceutical and Clinical Research (Asian J Pharm Clin Res), 2015, 8 (3), 96-98.
  4. Dinesh Kumar, Rajesh T, Sameer R Modi, Arvind K Bansal, Nalini R Shastri.; Effect of HPMC concentration on crystal habit of nifedipine. CrystEngComm, 2015, 17, 1615-1624.
  5. Saritha A, Nalini R Shastri. Semi solid matrix formulations of meloxicam and tenoxicam: an in vitro and in vivo evaluation. Arch Pharm Res. 2015, 38 801-812.
  6. Kalpana M., Ramakrishna Sistla, Nalini R Shastri.; Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug – an in vitro and an in vivo study. Drug Delivery, 2015, 22, 418-426.
  7. Abdul Bari Mohd, Krishna Sanka, Srikanth Bandi, Prakash V Diwan, Nalini Shastri,; Solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of glimepiride: development and antidiabetic activity in albino rabbits. Drug Delivery, 2015, 22, 499-508.
  8. Laxmi Narayana, Naveen Chella, Dinesh Kumar, and Nalini R. Shastri,; Design of a novel type IV lipid-based delivery system for improved delivery of drugs with low partition coefficient. J Liposome Res, 2015, 25, 325-33.
  9. Dinesh Kumar, Rajesh T, Nalini R Shastri,; Can vacuum morphologies predict solubility and Intrinsic Dissolution Rate? A Case Study with Felodipine Polymorph Form IV. Journal of Computational Science, 2015, 10, 178–185.
  10. Abdul Bari, Naveen Chella, Krishna Sanka, Nalini R. Shastri, and Prakash V. Diwan.; Improved anti-diabetic activity of glibenclamide using oral self nano emulsifying powder. J Microencapsul, 2015, 3254-60.
  11. Dinesh Kumar, Rajesh T, Sameer R Modi, Arvind K Bansal, Nalini R Shastri,; Effect of surfactant concentration on Nifedipine Crystal Habit and related pharmaceutical properties. Journal of crystal growth, 2015, 422, 44-51.
  12. Kodukula Sai Gouthami, Dinesh Kumar, Rajesh Thipparaboina, Rahul B. Chavan, Nalini R. Shastri,; Can crystal engineering be as beneficial as micronisation and overcome its pitfalls?: A case study with cilostazol. International Journal of Pharmaceutics, 2015, 491, 26-34.
  13. Rajesh Thipparaboina, Rahul B Chavan, Dinesh Kumar, Srivani Modugula, Nalini R Shastri,; Micellar Carriers for the Delivery of Multiple Therapeutic Agents. Colloids and Surfaces B: Biointerfaces, 2015, 135, 291–308
  14. Dinesh Kumar,RajeshThipparaboina, BojjaSreedhar, Nalini R. Shastri,; Role of surface chemistry in crystal morphology and its associated properties; CrystEngComm, 2015, 17, 6646.
  15. Rajesh Thipparaboina, Dinesh Kumar, Sudhir Mittapalli, Sridhar Balasubramanian, Ashwini Nangia,and Nalini R Shastri, Ionic, Neutral, and Hybrid Acid−Base Crystalline Adducts of Lamotrigine with Improved Pharmaceutical Performance; Cryst. Growth Des, 2015, 15, 5816–5826
  16. Dinesh Kumar, Rajesh Thipparaboina, and Nalini Shastri.; Impact of Nisoldipine Crystal Morphology on its Biopharmaceutical Properties: A Layer Docking Assisted Study. Org. Process Res. Dev., 2015, 19, 1912-1917
  17. Patel K, Chowdhury N, Doddapaneni R, Boakye CH, Chandraiah Godugu, Singh Mandip.; Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer. J Pharm Sci., 2015 Dec;104(12):4417-26.
  18. Chandraiah Godugu, Raman preet Singh, Rama Rao Poduri.; Nanotoxicology: Contemporary Issues and Future Directions, Book Chapter, Title Targeted Drug Delivery: Concepts and Design, Springer Link, 2015, pp 733-781.
  19. Thirupati Ajmeera, Sonia Gera, Sravanthi Reddy Pailla, Mallika A, Sujatha Dodoala, Sunitha Sampathi*.; “Enhancement of Dissolution and Bioavailability of Poorly Soluble Telmisartan: Designing modified Cyclodextrin Inclusion Complexes”. Journal of Chemical and Pharmaceutical Research (JCPR), 2015, 7(10):164-174.
  20. S.Sunitha, D. Sujatha, Kian paul Singh. “Antilithiatic Activity of phlorotannin rich extract of Sarghassum Wightii on Calcium Oxalate Urolithiais – In Vitro and In Vivo Evaluation”. International Braz J Uro, 2015, Vol. 41 (3): 511-520.
  21. S Sampathi*, S K Mankala, J Wankar, S Dodoala.; “Nano emulsion based Hydrogels of Itraconazole for Transdermal Drug Delivery”; Journal of Scientific & Industrial Research (JSIR), 2015, Vol. 74(02)88-92.
  22. Sunitha S, Nagarajan Venkataraman, Suman Pamukuntla, Jithender BanothPandu Boini, Veerabhadra Swami, Venu Talla.; “Platelet Augmentation Activity of Andrographis Paniculata Extract and Andrographolide against Cyclophosphamide Induced Thrombocytopenia in Rats”. Pharmacy & Pharmacology International Journal, 2015, Vol 2 (4):1-6.
  23. Sunitha Sampathi*, Sarika M, Vijay Kumar Y, Sujatha Dodoala, Sonia Gera.; “Biodegradable Polymeric Nanoparticles for Delivery of Combination of Antiretroviral Drugs”; Int.J. ChemTech Res. 2015, 7(2): 716-724.
  24. Kulhari, H., Pooja, D., Shrivastava, S., Telukutala, S., Barui, A., and Patra, C. et al.; Cyclic-RGDfK peptide conjugated succinoyl-TPGS nanomicelles for targeted delivery of docetaxel to integrin receptor over-expressing angiogenic tumours. Nanomedicine: Nanotechnology, Biology And Medicine, 2015, 11: 1511-1520.
  25. Resham. K., Patel. P., Thummuri. D., Guntuku. L., Shah. V., and Bambal. R.; et al.; Preclinical drug metabolism and pharmacokinetics of salinomycin, a potential candidate for targeting human cancer stem cells; Chemico-Biological Interactions, 2015, 240: 146-152.
  26. Muzammil Afzal, S., Naidu, V., Harishankar, N., and Kishan, V.; Albumin anchored docetaxel lipid nanoemulsion for improved targeting efficiency – preparation, characterization, cytotoxic, antitumor and in vivo imaging studies; Drug Delivery, 2015, 1-9.
  27. Pradipbhai D Kalariya, M.V.N. Kumar Talluri*, Prinesh N. Patel, R. Srinivas,; Rapid structural characterization of in-vivo and in-vitro metabolites of tinoridine using UHPLC-QTOF-MS/MS and in-silico toxicological screening of metabolites; Journal of Mass Spectrometry, 50 2015 1222–1233.
  28. Pradipbhai D. Kalariya, Prinesh N. Patel, Mahesh Sharma, Prabha Garg, R. Srinivas, M. V. N. Kumar Talluri*.; Characterization of stress degradation products of blonanserin by UPLC-QTOF-tandem mass spectrometry; RSC Adv., 5 2015 69273-288.
  29. J. Paulose, R. P. Achuthan, M. P. L. Linsha, George Mathai, B. Prasanth, M. V. N. Kumar Talluri and R. Srinivas, Protonated N-benzyl and N-(1-phenylethyl) tyrosine Amides Dissociate via ion/neutral Complexes, Rapid Commun; Mass Spectrom, 29 2015 1577–1584.
  30. Pradipbhai D Kalariya, Prinesh N. Patel, R. Srinivas, M.V.N. Kumar Talluri*.; A Quality by design approach for rapid, selective UPLC separation of dolutegravir- a novel anti-HIV drug degradation products: characterization of hydrolytic and photolytic degradation products by UPLC-QTOF-MS/MS; New Journal of Chemistry, 39 2015 6303-6314.
  31. M.V.N.Kumar Talluri*, Lubna Khatoon, Pradipbhai D Kalariya, Balasaheb B. Chavana, R. Srinivasa.; LC-MS/MS characterization of forced degradation products of fidarestat, a novel aldose reductase inhibitor: development and validation of a stability-indicating RP-HPLC method; Journal of chromatographic science, 2015, 53(9):1588-1596
  32. Pradipbhai D Kalariya, T. Jagadeshwar Reddy, Mahesh Sharma, Prabha Garg, T. Jagadeshwar Reddy, R. Srinivas, M.V.N. Kumar Talluri*.; LC-QTOF-MS/MS studies for characterization of degradation products of mirabegron under stressed conditions and in silico toxicity predictions of its degradation products; RSC Advances, 5 2015 31024-31038.
  33. M.V.N. Kumar Talluri*, Kundan Kumar Keshari, Pradipbhai D Kalariya, R. Srinivas.; Selective separation and characterization of the stress degradation products of ondansetron hydrochloride by liquid chromatography with quadrupole time-of-flight mass spectrometry; Journal of Separation Science, 38 2015 1625–1632.
  34. Vaibhav Anandgaonkar, Abhishek Gupta, Kona Srinivas, M.V.N. Kumar Talluri*.; Isolation, LC-MS/MS and 2D-NMR characterization of alkaline degradants of Tenofovir disoproxil fumarate; Journal of Pharmaceutical and Biomedical Analysis, 107 2015 175-185.
  35. Kumar, A., Yerra, V., and Malik, R.; Comment on Sharma. Mitochondrial Hormesis and Diabetic Complications; Diabetes. 2015 64, e32-e33.
  36. Kumar, A., Jeengar, M., and Naidu, V.; Re. “Sucrose, fructose, glucose and their link to metabolic syndrome and cancer”. Nutrition, 2015 31(1), 258-259.
  37. Sandireddy. R, Yerra. V, Komirishetti. P, Areti. A, Kumar. A.; Fisetin Imparts Neuroprotection in Experimental Diabetic Neuropathy by Modulating Nrf2 and NF-κB Pathways. Cellular and Molecular Neurobiology. 2015, 36(6), 883-892.
  38. Sai Giridhar Sarma Kandanur, Nageswara Rao Golakoti, Srinivas Nanduri, Synthesis and in vitro cytotoxicity of novel C-12 substituted-14-deoxy-andrographolide derivatives as potent anti-cancer agents. Bioorg. Med. Chem. Lett, 2015, 25 (24), 5781–5786
  39. Jakeer Pasha, Bhaskar Kandagatla, Saikat Sen, Guru Pavan Kumar Seerapu, Sushmitha Bujji, Devyani Haldar, Srinivas Nanduri, Srinivas Oruganti, Amberlyst-15 catalyzed Povarov reaction of N-arylidene-1H-indazol-6-amines and indoles: a greener approach to the synthesis of exo-1,6,7,7a,12,12a-hexahydroindolo[3,2-c]pyrazolo[3,4-f]quinolines as potential sirtuin inhibitors. Tetrahedron Letters, 2015, 56(18) 2289–2292
  40. Bandaru, S.; Akka, J.; Marri, V. K.; Alvala, M.; Ponnala, D.; Mundluru, H. P., Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics. Inflammation, 2015, 38 (6), 2146-55.
  41. A Kumar, M Jeenger, VGM Naidu.; Sugar sweet: the bitter truth. Re. “Sucrose, Fructose and Glucose and their link to metabolic syndrome and cancer”; Nutrition 31 (1), 2015, 258-259.
  42. Jain, E. Muntimadugu, A.J. Domb, W. Khan, in: S. Samal and P. Dubruel (Eds.).; Cationic Polymers in Regenerative Medicine, The Royal Society of Chemistry, 2015, pp. 228-248.
  43. Kamal, K. Sreekanth, N. Shankaraiah, M. Sathish, S. Nekkanti, V. Srinivasulu.; Dithiocarbamate/piperazine bridged pyrrolobenzodiazepines as DNA-minor groove binders: Synthesis, DNA-binding affinity and cytotoxic activity. Bioorganic Chemistry 59(0) 2015 23-30.
  44. Kamal, T.S. Reddy, M.V.P.S. Vishnuvardhan, V.D. Nimbarte, A.V. Subba Rao, V. Srinivasulu, N. Shankaraiah.; Synthesis of 2-aryl-1,2,4-oxadiazolo-benzimidazoles: Tubulin polymerization inhibitors and apoptosis inducing agents. Bioorganic & Medicinal Chemistry 23(15) 2015 4608-4623.
  45. Atulya Nagarsenkar, Santosh Kumar Prajapti, Sravanthi Devi Guggilapu, Bathini Nagendra Babu.; Aldehyde-Promoted One-Pot Regiospecific Synthesis of Acrylamides Using an in Situ Generated Molybdenum Tetracarbonyl Amine [Mo(CO)4(amine)2] Complex; Organic Letters, 2015, 17,4592
  46. Atulya Nagarsenkar, Santosh Kumar Prajapti, Bathini Nagendra Babu ,An Efficient Catalytic Reductive Amination: A Facile One-Pot Access to 1,2-dihydropyrrolo[3,4-b]indol-3(4H)-ones by using B(C6F5)3/NaBH4; Journal of chemical sciences, 2015, 127, 711.
  47. Kumar, R. Thipparaboina, S.R. Modi, A.K. Bansal, N.R. Shastri.; Effect of HPMC concentration on crystal habit of nifedipine. CrystEngComm 17(7) 2015 1615-1624.
  48. Sujatha , Kiranpal Singh , Mursalin Vohra , K. Vijay Kumar , S. Sunitha.; Antilithiatic Activity of phlorotannin rich extract of sarghassum Wightii on Calcium Oxalate urolithiais – In Vitro and InVivo Evaluation Int Braz J Urol 41 (3); 2015 ; 511-520.
  49. Debasish Swain, Prinesh N. Patel, Ilayaraja Palaniappan, Gayatri Sahu, Gananadhamu Samanthula, Liquid Chromatography-Tandem Mass Spectrometry Study of Forced Degradation of Azilsartan Medoxomil Potassium. Rapid Communications in Mass Spectrometry 29 (15) 2015 1437–1447.
  50. Dinesh Thummuri, Manish Kumar Jeengar, Shweta Shrivastava, Harishankar Nemani, Ravindar Naik Ramavat, Pradip Chaudhari, VGM Naidu.; Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling. Pharmacological Research, 99, 2015, 63–73
  51. Muntimadugu, A. Jain, W. Khan, in: P. V. Devarajan and S. Jain (Eds.), Targeted Drug Delivery : Concepts and Design. Springer International Publishing, 2015, pp. 341-365.
  52. Hitesh Kulhari, Deep Pooja, Shweta Shrivastava, Srinivasa R Telukutala, Ayan K Barui, Chitta Ranjan Patra, VGM Naidu, David J Adams, Ramakrishna Sistla.; Cyclic-RGDfK peptide conjugated succinoyl-TPGS nanomicelles for targeted delivery of docetaxel to integrin receptor over-expressing angiogenic tumours. Nanomedicine: Nanotechnology, Biology and Medicine,11, 2015, 1511–1520
  53. Singh, R. Swami, M.K. Jeengar, W. Khan, R. Sistla, p-Aminophenyl-a-d-mannopyranoside engineered lipidic nanoparticles for effective delivery of docetaxel to brain. Chemistry and Physics of Lipids, 188 2015 1-9.
  54. J. Pasha, B. Kandagatla, S. Sen, G.P.K. Seerapu, S. Bujji, D. Haldar, S. Nanduri, S. Oruganti, Amberlyst-15 catalyzed Povarov reaction of N-arylidene-1H-indazol-6-amines and indoles: a greener approach to the synthesis of exo-1,6,7,7a,12,12a-hexahydroindolo[3,2-c]pyrazolo[3,4-f]quinolines as potential sirtuin inhibitors. Tetrahedron Letters, 56(18) 2015 2289-2292.
  55. J. Paulose, R.P. Achuthan, M.P.L. Linsha, G. Mathai, B. Prasanth, M.V.N. Kumar Talluri, R. Srinivas.; Protonated N-benzyl- and N-(1-phenylethyl)tyrosine amides dissociate via ion/neutral complexes. Rapid Communications in Mass Spectrometry 29(17) 2015 1577-1584.
  56. K.R. Senwar, P. Sharma, S. Nekkanti, M. Sathish, A. Kamal, B. Sridhar, N. Shankaraiah.; A one-pot 'click' reaction from spiro-epoxides catalyzed by Cu(i)-pyrrolidinyl-oxazole-carboxamide. New Journal of Chemistry 39(5) 2015 3973-3981.
  57. Kamal, A.; Sathish, M.; Nayak, V. L.; Srinivasulu, V.; Kavitha, B.; Tangella, Y.; Thummuri, D.; Bagul, C.; Shankaraiah, N.; Nagesh, N.; Design and Synthesis of DNA-interactive C3-Dithiocarbamate Linked ß-Carboline Hybrids: Topoisomerase II Inhibition and Apoptosis Inducing Anticancer Activity; Bioorg. Med. Chem, 2015, 23, 5511–5526
  58. L.S. Duvvuri, S. Katiyar, A. Kumar, W. Khan.; Delivery aspects of antioxidants in diabetes management. Expert Opinion on Drug Delivery 12(5) 2015 827-844.
  59. M. Kalpana, R. Sistla, N.R. Shastri, Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug - an in vitro and an in vivo study. Drug Delivery 22(3) 2015 418-426.
  60. M.K. Jeenger, S. Shrivastava, V.G. Yerra, V.G.M. Naidu, S. Ramakrishna, A. Kumar.; Curcumin: A pleiotropic phytonutrient in diabetic complications. Nutrition 31(2) 2015 276-282.
  61. M.V.N. Kumar Talluri, S. Dharavath, P.D. Kalariya, B. Prasanth, R. Srinivas, Structural characterization of alkaline and oxidative stressed degradation products of lurasidone using LC/ESI/QTOF/MS/MS. Journal of Pharmaceutical and Biomedical Analysis 105 2015 1-9.
  62. M.V.N.K. Talluri, K.K. Keshari, P.D. Kalariya, R. Srinivas, Selective separation and characterization of the stress degradation products of ondansetron hydrochloride by liquid chromatography with quadrupole time-of-flight mass spectrometry. Journal of Separation Science 38(10) 2015 1625-1632.
  63. M.V.N.K. Talluri, L. Khatoon, P.D. Kalariya, B.B. Chavan, S. Ragampeta.; LC/MS-MS characterization of forced degradation products of Fidarestat, a novel aldose reductase inhibitor: Development and validation of a stability-indicating RP-HPLC method. Journal of Chromatographic Science, 2015.
  64. MK Jeenger, S Shrivastava, YV Yerra, VGM Naidu, R Sistla, A Kumar.; Curcumin: A Pleiotropic Phytonutrient in Diabetic Complications; Nutrition 31 (2), 2015, 276-282.
  65. N. Beyth, Y. Houri-Haddad, A. Domb, W. Khan, R. Hazan, Alternative antimicrobial approach: nano-antimicrobial materials. Evidence-Based Complementary and Alternative Medicine 2015(246012) 2015 1-16.
  66. N. Chella, R. Tadikonda.; Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs-a case study with valsartan. Drug Development and Industrial Pharmacy 41(6) 2015 888-897.
  67. N. Satheeshkumar, S. Shantikumar, David Paul.; An Insight into Chemometrics Concepts in Pharmaceutical Analysis. J. Pharm. Inn. Res., 2 2015, 24 – 33.
  68. N. Shankaraiah, K.P. Siraj, S. Nekkanti, V. Srinivasulu, P. Sharma, K.R. Senwar, M. Sathish, M.V.P.S. Vishnuvardhan, S. Ramakrishna, C. Jadala, N. Nagesh, A. Kamal.; DNA-binding affinity and anticancer activity of ß-carboline–chalcone conjugates as potential DNA intercalators: Molecular modelling and synthesis. Bioorganic Chemistry 59(0) 2015 130-139.
  69. Nagarajan Venkataraman, Suman Pamukuntla, Jithender Banoth, Pandu Boini, Sunitha Sampathi, Veerabhadra Swami, Venu Talla.; Platelet Augmentation Activity of Andrographis Paniculata Extract and Andrographolide against Cyclophosphamide Induced Thrombocytopenia in Rats. Pharm Pharmacol Int J2(4) 2015, 29.
  70. P.D. Kalariya, M. Sharma, P. Garg, J.R. Thota, S. Ragampeta, M.V.N.K. Talluri.; Characterization of stress degradation products of mirabegron using UPLC-QTOF-MS/MS and in silico toxicity predictions of its degradation products. RSC Advances 5(39) 2015 31024-31038.
  71. P.D. Kalariya, P.N. Patel, C.V. Swamy, R. Srinivas, M.V.N.K. Talluri.; A validated liquid chromatography mass spectrometry method for the quantification of tinoridine hydrochloride in rat plasma and its application to pharmacokinetic studies. Analytical Methods 7(5) 2015 1965-1970.
  72. P.D. Kalariya, P.N. Patel, R. Srinivas, M.V.N.K. Talluri.; Quality by design based development of a selective stability-indicating UPLC method of dolutegravir and characterization of its degradation products by UPLC-QTOF-MS/MS. New Journal of Chemistry 39(8) 2015 6303-6314.
  73. P.N. Patel, D. Rajesh Kumar, S. Gananadhamu, R. Srinivas.; Characterization of the stress degradation products of tolvaptan by UPLC-Q-TOF-MS/MS. RSC Advances 5(27) 2015 21142-21152.
  74. P.N. Patel, P.D. Kalariya, M. Sharma, P. Garg, M.V.N.K. Talluri, S. Gananadhamu, R. Srinivas.; Characterization of forced degradation products of pazopanib hydrochloride by UHPLC-Q-TOF/MS and in silico toxicity prediction Journal of Mass Spectrometry 50(7) 2015 918-928.
  75. P.N. Patel, R.M. Borkar, P.D. Kalariya, R.P. Gangwal, A.T. Sangamwar, G. Samanthula, S. Ragampeta.; Characterization of degradation products of Ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis. Journal of Mass Spectrometry 50(2) 2015 344-353.
  76. Pradipbhai D Kalariya, M.V.N. Kumar Talluri*, Prinesh N Patel, R. Srinivas.; Identification of hydrolytic and isomeric N-oxides oxidative degradants of vilazodone by on-line LC-ESI-MS/MS and APCI-MS. Journal of Pharmaceutical and Biomedical Analysis 102 2015 353-365.
  77. Pradipbhai D. Kalariya, Prinesh N. Patel, Mahesh Sharma, Prabha Garg, R. Srinivas, M. V. N. Kumar Talluri*.; Characterization of stress degradation products of blonanserin by UPLC-QTOF-tandem mass spectrometry, RSC Adv., 5 2015 69273-288.
  78. Pradipbhai D Kalariya, M.V.N. Kumar Talluri*, Prinesh N. Patel, R. Srinivas.; Rapid structural characterization of in-vivo and in-vitro metabolites of tinoridine using UHPLC-QTOF-MS/MS and in-silico toxicological screening of metabolites, Journal of Mass Spectrometry 50 2015 1222–1233
  79. Prathama S. M, Sumana C, T. Srujana, Libi Anand V, S. K. Prajapti, K. Bhanu Chandra, Lenin V., Bathini Nagendra Babu; Synthesis and biological evaluation of strained unusual amino acid containing tetrapeptides as potential antidepressant agents; Bioorganic Chemistry, 2015, 53, 63
  80. Prinesh N. Patel, Pradipbhai D. Kalariya, S Gananadhamu, R. Srinivas.; Forced degradation of fingolimod: Effect of co-solvent and characterization of degradation products by UHPLC-Q-TOF–MS/MS and 1H NMR. Journal of Pharmaceutical and Biomedical Anaysis 115 2015 388-394.
  81. Prinesh N. Patel.; Vijaya Saradhi Karakam.; Gananadhamu S.; Srinivas R.; Quality-by-design-based ultra high performance liquid chromatography related substances method development by establishing the proficient design space for sumatriptan and naproxen combination. J. Sep. Sci. 2015, 38(19), 3354-62.
  82. R. Swami, I. Singh, H. Kulhari, M. Jeengar, W. Khan, R. Sistla.; p-Hydroxy benzoic acid-conjugated dendrimer nanotherapeutics as potential carriers for targeted drug delivery to brain: an in vitro and in vivo evaluation. Journal of Nanoparticle Research 17(6) 2015 1-11.
  83. R. Swami, I. Singh, M.K. Jeengar, V.G.M. Naidu, W. Khan, R. Sistla.; Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting. International Journal of Pharmaceutics 486(1-2) 2015 287-296.
  84. R.S. Khan, M. Senthi, P.C. Rao, A. Basha, M. Alvala, D. Tummuri, H. Masubuti, Y. Fujimoto, A.S. Begum.; Cytotoxic constituents of Abutilon indicum leaves against U87MG human glioblastoma cells. Natural Product Research 29(11) 2015 1069-1073.
  85. S. Alladi, N. Shastri, Semi solid matrix formulations of meloxicam and tenoxicam: an in vitro and in vivo evaluation. Archives of Pharmacal Research 38(5) 2015 801-812.
  86. S. Bandaru, G. Tiwari, J. Akka, V.K. Marri, M. Alvala, V.R. Gutlapalli, A. Nayarisseri, H.P. Mundluru.; Identification of high affinity bioactive Salbutamol conformer directed against mutated (Thr164Ile) beta 2 adrenergic receptor. Current Topics in Medicinal Chemistry 15(1) 2015 50-56.
  87. S. Bandaru, V. Marri, J. Akka, M. Alvala, H. Mundluru.; Association of transforming growth factor-beta 1 promoter variant -509 C/T with bronchial asthma in south Indian population. Inflammation 38(1) 2015 409-414.
  88. S. Doppalapudi, S. Katiyar, A.J. Domb, W. Khan, in: F. Puoci (Ed.), Advanced Polymers in Medicine, Springer International Publishing, 2015, pp. 33-66.
  89. S. K. Prajapti, Atulya N, Sravanthi Devi G., Bathini Nagendra Babu.; B(C6F5)3 as versatile catalyst: An efficient and mild protocol for the one-pot synthesis of functionalized piperidines and 2-substituted benzimidazole derivatives; Tetrahedron Letters, 2015, 56, 6795
  90. S. Shantikumar, B. Prashanth, Ch. Veerabhadra Swamy, R. Srinivas, N. Satheeshkumar.; Novel approach for pharmacokinetic and protein binding study of Teneligliptin using high resolution accurate mass spectrometer and ultrafiltration: in-vitro and in-vivo estimation. Proceedings of 63rd ASMS conference on Mass spectrometry and allied topics, J Am. Soc. Mass Spectrom. 26 2015, 1-236.
  91. S. Shantikumar, N. Satheeshkumar, R. Srinivas.; Pharmacokinetic and protein binding profile of peptidomimetic DPP-4 inhibitor – Teneligliptin in rats using liquid chromatography–tandem mass spectrometry. Journal of Chromatography B, 1002, 2015, 194–200.
  92. S. Shantikumar, N. Satheeshkumar, B. Prasanth, A. Lingesh, D. Paul, R. Srinivas.; A sensitive and selective liquid chromatography mass spectrometry method for simultaneous estimation of anti-diabetic drugs inhibiting DPP-4 enzyme in human plasma: overcoming challenges associated with low recovery and sensitivity. Analytical Methods 7(15) 2015 6198-6206.
  93. S. Shrivastava, M.K. Jeengar, V.S. Reddy, G.B. Reddy, V.G.M. Naidu, Anticancer effect of celastrol on human triple negative breast cancer: Possible involvement of oxidative stress, mitochondrial dysfunction, apoptosis and PI3K/Akt pathways. Experimental and Molecular Pathology 98(3) 2015 313-327.
  94. S. Vadlamani.; Review on statins future perspective. Research Journal of Pharmaceutical, Biological and Chemical Sciences 6(2) 2015 471-475.
  95. S.K. Prajapti, S. Shrivastava, U. Bihade, A.K. Gupta, V.G.M. Naidu, U.C. Banerjee, B.N. Babu.; Synthesis and biological evaluation of novel ?2-isoxazoline fused cyclopentane derivatives as potential antimicrobial and anticancer agents. MedChemComm 6(5) 2015 839-845.
  96. Santosh Kumar Prajapti, Keshav Kumar Gupta, Bathini Nagendra Babu.; B(C6F5)3 catalyzed one-pot three-component Biginelli reaction: An efficient and environmentally benign protocol for the synthesis of 3,4-dihydropyrimidin-2(1H)-ones/thiones; Journal of chemical sciences, 2015, 127,1047
  97. Satheeshkumar N, L. Allakonda, V. Chiguru, S. Saladi, P. Jhansi Rani.; Whole Brain Cholinesterase Inhibition - Invitro And Exvivo Estimation Using Desmodium Gangeticum and its Constituents. 12th International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders (AD/PDTM 2015). Neurodegener Dis 15 2015,1-1969.
  98. Satheeshkumar, N; Kumaraswamy R., Shantikumar S., Paul D.; QBD Based Rp-HPLC Method For Screening And Analysis Of Telapravir And 7 Other Antiretroviral Agents. Indian Drugs, 52, 2015, 20-33.
  99. Senwar, K. R.; Sharma, P.; Reddy, T. S.; Jeengar, M. K.; Nayak, V. L.; Naidu, V. G. M.; Kamal, A. Shankaraiah, N.; Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies; Eur. J. Med. Chem. 2015, 102, 413–424
  100. Shankaraiah, N.; Kumar, N. P.; Amula, S. B.; Nekkanti, S.; Jeengar, M. K.; Naidu, V. G. M.; Reddy, T. S.; Kamal, A.; Novel podophyllotoxin-thiourea congeners as DNA topoisomerase-II inhibition and apoptosis inducing agents: Synthesis, anticancer activity and molecular modeling studies; Bioorg. Med. Chem. Lett. 2015 , 25, 4239–4244
  101. Sravanthi Devi Guggilapu, Santosh Kumar Prajapti, Bathini Nagendra Babu.; An efficient one-pot oxidative esterification of aldehydes to carboxylic esters using B(C6F5)3–TBHP; Tetrahedron Letters>. 2015, 56, 889.
  102. Sravanthi Devi G., S. K. Prajapti, Atulya N., G. Lalita, V.G.M. Naidu and Bathini Nagendra Babu.;MoO2Cl2 catalyzed efficient synthesis of functionalized 3,4-dihydropyrimidin-2(1H)-ones / thiones and polyhydroquinolines: Recyclability, Fluoroscence and Biological studies; New Journal of Chemistry (RSC), 40, 2015, 838
  103. Swain D.; Sahu G.; Samanthula G. Rapid LC-MS compatible stability indicating assay method for azilsartan medoxomil potassium. J. Anal. Bioanal. Tech. 2015, 6, 254.
  104. V. Anandgaonkar, A. Gupta, S. Kona, M.V.N.K. Talluri.; Isolation, LC-MS/MS and 2D-NMR characterization of alkaline degradants of tenofovir disoproxil fumarate. Journal of Pharmaceutical and Biomedical Analysis 107 2015 175-185.
  105. Shraddha Chowshary, Bhavesh Mor.; A study of Product Life Cycle Extension Strategies of Patented Drugs to deter entry of generics. International Journal of Pharmaceutical Science and Health Care, 5 (3), 2015, 98-117.
  106. Lakshmi B.; Perceptual gap analysis of Pharmaceutical OTC products: Consumers and Product Executives. International Journal of Innovative Pharmaceutical Sciences and Research, 2015, 18-38
  107. B.Lakshmi.; Factors affecting the Investment Behaviour of Women. International Journal of Management and Social Sciences 9(3), 2015, 185 - 197.